Gilead Sciences Inc. - GILD (NASDAQ-GS)

0.57 (-0.71%)
Quotes delayed 15 mins. Currently January 18, 2018 4:20:27 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Gilead develops and markets products in the HIV/AIDS, liver diseases, respiratory and cardiovascular therapeutic areas

Key Financials

Day Range:80.77 - 81.65
52 Week Range:63.76 - 86.27
Market Cap:106.03B
P/E Ratio:9.30
Div Yield:2.55
Previous close
No Chart Available
Purchase GILD in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of GILD not only as a single stock, but also as part of a motif.
Professional Motifs with GILD
Biotech Breakthroughs
Biotech Breakthroughs 13.2% 1 YR RTN Biotech firms are breathing new life into hope for cures for complex diseases like cancer, arthritis and AIDS.
View all professional motifs with GILD
Community Motifs with GILD
Innovation Ahead
Innovation Ahead 14.4% 1 YR RTN
Biotech Recovery
Biotech Recovery -- 1 YR RTN
HitBig -- 1 YR RTN
JNJ Winners
JNJ Winners 31.9% 1 YR RTN
View all community motifs with GILD
What Others Think About GILD
Emily Mullin
We mapped where the two approved CAR-T cell therapies are available. Lots of holes in rural America, where cancer a……
56 63
Kathryn Windham
Sterneck Capital Management Trimmed By $443,313 Its Gilead Sciences $GILD Stake…
Alessandra the $AMD Long
In $IBB mkts it was/is called the "What would $GILD pay for" maybe better named just "who will $AAPL take out"…
Margaret Simmons
American Research & Management Increased Its Gilead Sciences $GILD Position by $392,445 ...
Beefing up its #CAR -T pipeline, $GILD teams up with $PFE on a lymphoma combo #cancer #phamra…
Related Companies Within The Biotechnology Sector
TiGenix - 42.19
Amgen Inc. - 187.59
Biogen Inc. - 344.44
Shire plc - 145.69